Company Profile

Epolin Inc
Profile last edited on: 11/1/2023      CAGE: 1CY34      UEI: J2Z7DA9A6G68

Business Identifier: Laser absorbing dyes and infra red dyes.
Year Founded
1983
First Award
1985
Latest Award
1987
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

358-364 Adams Street
Newark, NJ 07105
   (973) 465-9495
   info@epolin.com
   www.epolin.com
Location: Multiple
Congr. District: 10
County: Essex

Public Profile

Epolin Inc merged with Polymathes Holdings LLC in March 2012. The company is a specialized chemical company engaged in the manufacturing, marketing, research and development of dyes and dye formulations which are used for a wide variety of products such as laser protection, welding visors, sunglasses, optical filters, glazing and imaging and security inks. The dyes are sold as pure, crystalline, powders or as formulations or mixtures of dyes. These formulations block a wider segment of the spectrum than any single pure dye can do. They are also sold as compositions in plastics and resins as well as liquid compositions used in ink applications and for coating surfaces. Headquartered in New Jersey, they also have offices in the Netherlands, in Japan and in China. In 2012, they were acquired by Polymathes Holdings, LLC, and now operate as a subsidiary.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : EPLN
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1987 2 AF $545,005
Project Title: Use of expanding monomer compositions for aircraft transparency coatings
1986 1 NIH $50,000
Project Title: Dental restoratives from polymers that expanded when cured

Key People / Management

  Greg Amato -- CEO

  James Ivchenko -- Principal Financial Officer

  Murray S Cohen -- Chairman of the Board

Company News

There are no news available.